openPR Logo
Press release

Meningococcal Vaccines Market | Rising Incidence of Meningococcal Disease Propels Demand

08-01-2018 08:26 PM CET | Health & Medicine

Press release from: Transparency Market Research

Meningococcal Vaccines Market | Rising Incidence

The global Meningococcal Vaccines Market consists of a good number of established players who are on a quest to expand their market shares. The competition in the market has been stiffening over the past decade, partly due to the innovative business strategies of leading players, and majorly on account of the continual entry of new players. The companies operating in the pharmaceutical industry can easily expand their horizons by manufacturing meningococcal vaccines and this is the prime reason behind the emergence of new market players. The established market vendors have attained a deft level of expertise in the manufacture, sale, and marketing of products, thus, enhancing their growth prospects in the contemporary times.

On the other hand, the smaller market vendors in the global meningococcal vaccines market are expected to form strategic alliances to counter the strong footholds of the leading players. The manufacture of novel drugs by leading players such as Sanofi, GSK, and Pfizer has resulted in an increased share of these players in the total market share. Besides all of the aforementioned factors, the decisive factor in the growth of the market vendors is the expertise with conducting core research in the field of meningococcal vaccines.Other key vendors in the global market for meningococcal vaccines are Biomed Pvt. Ltd., Serum Institute of India Ltd., Baxter International Inc., Nuron Biotech, Novartis International AG, and GlaxoSmithKline plc.

A report by Transparency Market Research (TMR) is an aplomb description of the global market for meningococcal vaccines. The report estimates that the global market would settle at an astral CAGR of 12.40% over the period between 2014 and 2022. Furthermore, the researchers of the report predicted that the global market for meningococcal vaccines would accumulate revenues worth USD 4.450.4 million by 2022.

Request to View Sample of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1666

Rising Incidence of Meningococcal Disease Propels Demand

The occurrence of meningococcal disease relies on several factors inclusive of age, geographical location, environmental fettle, and immunity. Such a wide range of factors responsible for the diseases also increases its rate of incidence, and this gives an impetus to the growth of the global market for meningococcal vaccines. The rising incidence of the disease is rebutted by the awareness campaigns to inform and educate people about the ills of meningococcal disease and ways to prevent and treat it. This has also created growth spaces for the pharmaceutical companies manufacturing vaccines and drugs for the treatment of meningococcal. The efforts of international bodies towards building a strong healthcare awareness framework have also aided the growth of the global market. Subsidization of vaccinations and mandates from global healthcare bodies have also benefitted the global market for meningococcal diseases.

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1666

Cost Wars could hamper Market Growth

The cost wars that have cropped with from the drug makers of similar vaccines is expected to hamper the growth of the global market. Furthermore, the penetration of the market into regions with strict regulatory framework for the manufacture of drugs is also a hindrance to market growth. There have been several attempts to build a robust base for research and development of antibodies in key European regions but to no avail. Nevertheless, the efforts of the leading vendors to capture maximum regional share is expected to enhance the growth prospects of the global market for meningococcal disease.

View Report -

https://www.transparencymarketresearch.com/meningococcal-vaccines-market.html

About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Meningococcal Vaccines Market | Rising Incidence of Meningococcal Disease Propels Demand here

News-ID: 1157705 • Views:

More Releases from Transparency Market Research

Non-Destructive Testing Market Projected to Reach $31.9 Billion by 2034: TMR Analysis
Non-Destructive Testing Market Projected to Reach $31.9 Billion by 2034: TMR Ana …
The Global Non-Destructive Testing (NDT) Market (비파괴 검사(NDT) 시장) is set to witness significant growth, projected to reach an estimated value of $31.9 billion by the end of 2034. This growth trajectory follows a valuation of $15.5 billion in 2023, fueled by a compound annual growth rate (CAGR) of 6.7% from 2024 to 2034. The increase in demand for inspection and health monitoring of concrete and steel structures is a primary
Outdoor Power Equipment Market Set to Reach $42.8 Billion by 2034, Driven by Sustainable Solutions and Growing Landscaping Demand
Outdoor Power Equipment Market Set to Reach $42.8 Billion by 2034, Driven by Sus …
The Global Outdoor Power Equipment Market (屋外用電動機器市場), valued at $30.5 billion in 2023, is projected to experience robust growth over the next decade. According to recent industry analysis, the market is expected to grow at a compound annual growth rate (CAGR) of 3.1%, reaching an estimated $42.8 billion by 2034. This growth is largely attributed to the increasing adoption of landscaping services and a rising demand for sustainable solutions in
Global Semiconductor IP Market to Reach $13.5 Billion by 2034, Growing at a 5.9% CAGR: TMR Analysis
Global Semiconductor IP Market to Reach $13.5 Billion by 2034, Growing at a 5.9% …
The Global Semiconductor Intellectual Property (IP) Market (반도체 지적재산권(IP) 시장), valued at US$ 7.1 billion in 2023, is projected to grow at a compound annual growth rate (CAGR) of 5.9% from 2024 to 2034, reaching US$ 13.5 billion by the end of the forecast period. This growth is primarily fueled by increasing demand for AI-based applications across various industries and government initiatives aimed at modernizing defense technologies. Download Sample PDF from
Glass Wafer Carrier Market to Surge, Expected to Reach $2.2 Billion by 2031: TMR Analysis
Glass Wafer Carrier Market to Surge, Expected to Reach $2.2 Billion by 2031: TMR …
The Global Glass Wafer Carrier Market (ガラスウェーハキャリア市場) is poised for significant growth, expected to reach a valuation of US$ 2.2 billion by 2031, advancing at a remarkable CAGR of 19.2% from 2024. The surge in demand for semiconductors in automotive and IT & telecommunications sectors is driving this trend, positioning glass wafer carriers as critical components in semiconductor manufacturing processes. Analysts indicate that the automotive industry's increased focus on vehicle safety,

All 5 Releases


More Releases for Meningococcal

Meningococcal Vaccines Market
Meningococcal Vaccines Market 2022 The Meningococcal Vaccines Market is expected to grow on an unabashed note in the next decade. With a worldwide shortage of healthcare staff, the healthcare IT solutions comprising web-based staffing platforms are doing the rounds. The future scenario won't be any different. These platforms would show the gaps, i.e. actual dearth of healthcare personnel like nurse's doctors, technicians, lab workers, and clinicians, which would help the entire
Meningococcal Vaccines Market Report Up to 2031
Visiongain has published a new report on Meningococcal Vaccines Market Report 2021-2031: Forecasts by Vaccine Type (Conjugate, Polysaccharide, Others), by End-user (Paediatric, Adult, Traveler), by Brand (Bexsero, Menactra, Menveo, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery Scenarios. Download Exclusive Sample of Report @ https://www.visiongain.com/report/meningococcal-vaccines-market-2021/#download_sampe_div Rise in prevalence of meningitis, increasing initiatives by government and regulatory authorities coupled strong funding support from non-profit organizations
Global Meningococcal Vaccines Market Research Report
This report studies the global Meningococcal Vaccines market status and forecast, categorizes the global Meningococcal Vaccines market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report GlaxoSmithKline JN-International Medical Novartis International Sanofi Pfizer Baxter International Geographically, this report studies the top producers and
Meningococcal Vaccines Market Growth by 2028 | GlaxoSmithKline, Polysaccharide M …
Partnerships between the private sector and public institutions have been the chief agenda of global public health initiatives. The last few years have witnessed an increase in several private-public partnerships specifically focussing on vaccine provision in developing countries. Partnerships like the International Coordinating Group on Vaccine Provision for Epidemic Meningitis Control (ICG) help magnify the vaccine outreach to remote areas of the world with the maximum need. The governments of
Meningococcal Vaccines Market: Regional & Competitive Analysis
A new Transparency Market Research report states that the global meningococcal vaccines market stood at US$1.5 bn in 2013 and is predicted to reach US$4.4 bn in 2022. It is expected to expand at a CAGR of 12.40% from 2014 to 2022. The title of the report is “Meningococcal Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2022”. View Full Report: http://www.transparencymarketresearch.com/meningococcal-vaccines-market.html As per the
Meningococcal Vaccines Market to Reach US$4.4 bn by 2022, Concerns over Increasi …
Global Meningococcal Vaccines Market: Snapshot Meningococcal disease is caused by Neisseria meningitides, a gram-negative bacterium, and the majority of infections are caused by six serogroups out of many. The disease is mainly prevalent in infants, adolescents, and people suffering with risk of asplenia. The growing morbidity and mortality of meningococcal disease among vast populations has made it a global concern. Read the Comprehensive Overview of Meningococcal Vaccines Market: http://www.transparencymarketresearch.com/meningococcal-vaccines-market.html The incidence of invasive